SANTA BARBARA, Calif.--(BUSINESS WIRE)--
QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB), a leading provider of enterprise software and services for global manufacturers, announced that Vitatech® Nutritional Sciences Inc. has implemented the new quality capabilities within QAD Enterprise Applications. The enhanced QAD quality control framework allows Vitatech to track and report on ingredients used in different lots, batches and stages of their manufacturing processes.
Vitatech is a leader in the nutritional supplement, formulation and manufacturing industry.Known by its global customers for its dedication to superior quality, Vitatech manufactures nutritional solutions in tablet, two-piece capsule and powder form in accordance with the United States Federal Drug Administration’s (FDA), current Good Manufacturing Practices (cGMPs) for Dietary Supplements. The company’s international and domestic business is based on customers that demand unique combinations of products and services. The trusted manufacturer provides their products and formulas to private-label clients, including big-box retail franchises around the world. The well-known formulas from CinSulin® and Mamalicious® are among the leading brands from multi-national companies that make Vitatech their private label nutraceutical partner of choice.
Vitatech Continues to Optimize its Manufacturing Processes with Advances in QAD ERP
As Vitatech continues to expand their operations to support their growing global customer base, the company must also meet increasing regulatory requirements for controls and reporting. In recent years, Vitatech has made significant investments in enterprise resource planning (ERP) solutions to help meet the unique requirements of their customers while delivering a competitive advantage.
As part of their recent upgrade to QAD Enterprise Applications, Vitatech deployed the latest capabilities in QAD’s quality control framework to support quality control throughout their manufacturing processes. “The advancements in QAD’s quality framework support Vitatech’s strategy for delivering the highest quality products with cost-effective, continually enhanced process efficiency,” said Thomas T. Tierney, CEO of Vitatech. “Upgrading our QAD ERP system provides us with a robust foundation for meeting the evolving Life Science requirements for traceability, analytical reporting and regulations for international commerce.”
As part of their system upgrade Vitatech has deployed the enhanced quality control and lot trace workbench, which are part of the Life Sciences Edition of QAD Enterprise Applications. With the QAD solution Vitatech has even greater capabilities to address regulatory mandates for product traceability. The enhancements to QAD quality control framework support detailed recording of quality attributes and traceability of materials throughout the supply chain from a single access point that supports backwards and forwards navigation through lot data.
Using the enhanced capabilities of the QAD quality control framework, Vitatech can achieve its goals for continual process improvement to achieve the following:
QAD Quality Control Ensures Continuous Process Improvement on a Global Scale
“From the start, the QAD team has worked closely with us to extract greater value from our ERP-- to match demand and supply while optimizing critical resources as we expand our global business,” said Toni Clubb, chief financial officer at Vitatech. “The latest evolution of QAD Enterprise Applications, shaped specifically for Life Sciences, allows us to put quality at the core of every business process, facilitate business with our partners and makes it easier for us to maintain global regulatory compliance.”
Additionally as part of the upgrade, Vitatech has implemented QAD’s managed electronic data interchange (EDI) solution. QAD managed EDI simplifies collaboration and helps reduce costs with advanced capabilities that facilitate business with Vitatech’s global retail partners.
“As one of the most respected and innovative manufacturers of nutraceuticals around the world, Vitatech is well equipped to expand its global reach and ensure it maintains its unsurpassed quality standards while continually optimizing process efficiency,” said Dave Medina, vice president of Life Sciences. “QAD’s vision for the Effective Enterprise in Life Sciences is focused on helping our customers, like Vitatech, perform at their best as they innovate and manufacture safe and effective healthcare products.”
For more information about QAD Enterprise Applications, please visit: www.qad.com.
Based in Tustin, CA, Vitatech Nutritional Sciences, Inc. is a recognized market leader in the contract manufacturing and private labeling of vitamins and supplements. The company manufactures tablets, two-piece capsules and powders in an FDA-licensed, dietary supplement/food cGMP environment. Vitatech offers a modern analytical laboratory; innovative formulation design; high-volume/high speed, technologically advanced equipment; packaging services; and rigorous quality assurance. Since its founding in 1954, Vitatech has embraced the highest quality and leadership standards, serving private-label clients in more than 22 countries.
About QAD – The Effective Enterprise
QAD Inc. (NASDAQ: QADA) (NASDAQ: QADB), is a leading provider of enterprise software and services designed for global manufacturing companies. For more than 30 years, QAD has provided global manufacturing companies with an enterprise resource planning (ERP) system that supports operational requirements; including financials, manufacturing, demand and supply chain planning, customer management, business intelligence and business process management. QAD offers flexible deployment options like QAD On Premise software and QAD On Demand software-as-a-service. Customers can operate in a blended environment where some users can be deployed On Premise and some users deployed via On Demand while offering the same end-user experience. With QAD, customers and partners in the automotive, consumer products, food and beverage, high technology, industrial products and life sciences industries can better align daily operations with their strategic goals to meet their vision of becoming more Effective Enterprises.
For more information about QAD, telephone +1 805-566-6000, visit www.qad.com
“QAD” is a registered trademark of QAD Inc. All other products or company names herein may be trademarks of their respective owners.
Note to Investors: This press release contains certain forward-looking statements made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Words such as “expects”, “believes”, “anticipates”, “could”, “will likely result”, “estimates”, “intends”, “may”, “projects”, “should”, and variations of these words and similar expressions are intended to identify these forward looking statements. Forward-looking statements are based on the company’s current expectations and assumptions regarding its business, the economy and future conditions. A number of risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements. These risks include, but are not limited to, evolving demand for the company's software products and products that operate with the company's products; the company's ability to sustain license and service demand; the company's ability to leverage changes in technology; the company's ability to sustain customer renewal rates at current levels; the publication of opinions by industry and financial analysts about the company, its products and technology; the reliability of estimates of transaction and integration costs and benefits; the entry of new competitors or new offerings by existing competitors and the associated announcement of new products and technological advances by them; delays in localizing the company's products for new or existing markets; the ability to recruit and retain key personnel; delays in sales as a result of lengthy sales cycles; changes in operating expenses, pricing, timing of new product releases, the method of product distribution or product mix; timely and effective integration of newly acquired businesses; general economic conditions; exchange rate fluctuations; and, the global political environment. In addition, revenue and earnings in the enterprise resource planning (ERP) software industry are subject to fluctuations. Software license revenue, in particular, is subject to variability with a significant proportion of revenue earned in the last month of each quarter. Given the high margins associated with license revenue, modest fluctuations can have a substantial impact on net income. Investors should not use any one quarter's results as a benchmark for future performance. For a more detailed description of the risk factors associated with the company and the industries in which it operates, please refer to the company's Annual Report on Form 10-K for fiscal 2013 ended January 31, 2013, and in particular, the section entitled “Risk Factors” therein, and in other periodic reports the company files with the Securities and Exchange Commission.